It is widely accepted that the rate of cancer progression varies between individuals and that this variation exceeds random expectation. This variation is apparent to the clinician who observes patients with similar disease relapse at different intervals after primary treatment. In biological terms, tumors of the same histological type are observed to grow at different rates in different patients. To a large extent, tumor recurrence can be predicted, but much of the variance remains unexplained.